The placebo group performed to well for a bad illness with an always advertised no valuable cure.
This results has been fishy and the outcome has been a killing.
I repeat that this product was not an hard to analyze ingested pill, but a progress visible topical product.
If $70 million spent was not good enough to assess a easy visible topical product, all the management has to be kicked out in the ass.
There is no justification for this failure. All was supposed to be a de-risked Investment.
It is a fact that in the years the directors and the consultants made out a living from our hard earned money.
- Forums
- ASX - By Stock
- Ann: TOV: Panel Receives Application
The placebo group performed to well for a bad illness with an...
-
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add FTT (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
NXD
NEXTED GROUP LIMITED
Nick Poll, Managing Director
Nick Poll
Managing Director
SPONSORED BY The Market Online